Cargando…

Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017

BACKGROUND: Malaria rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen are widely used for detection of active infection with this parasite and are the only practical malaria diagnostic test in some endemic settings. External val...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogier, Eric, Bakari, Catherine, Mandara, Celine I., Chiduo, Mercy G., Plucinski, Mateusz, Nace, Douglas, Battle, Nastassia, Chacky, Franky, Rumisha, Susan F., Molteni, Fabrizio, Mandike, Renata, Mkude, Sigsbert, Njau, Ritha, Mohamed, Ally, Udhayakumar, Venkatachalam, Ishengoma, Deus S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714097/
https://www.ncbi.nlm.nih.gov/pubmed/36457087
http://dx.doi.org/10.1186/s12936-022-04383-4
_version_ 1784842150839582720
author Rogier, Eric
Bakari, Catherine
Mandara, Celine I.
Chiduo, Mercy G.
Plucinski, Mateusz
Nace, Douglas
Battle, Nastassia
Chacky, Franky
Rumisha, Susan F.
Molteni, Fabrizio
Mandike, Renata
Mkude, Sigsbert
Njau, Ritha
Mohamed, Ally
Udhayakumar, Venkatachalam
Ishengoma, Deus S.
author_facet Rogier, Eric
Bakari, Catherine
Mandara, Celine I.
Chiduo, Mercy G.
Plucinski, Mateusz
Nace, Douglas
Battle, Nastassia
Chacky, Franky
Rumisha, Susan F.
Molteni, Fabrizio
Mandike, Renata
Mkude, Sigsbert
Njau, Ritha
Mohamed, Ally
Udhayakumar, Venkatachalam
Ishengoma, Deus S.
author_sort Rogier, Eric
collection PubMed
description BACKGROUND: Malaria rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen are widely used for detection of active infection with this parasite and are the only practical malaria diagnostic test in some endemic settings. External validation of RDT results from field surveys can confirm appropriate RDT performance. METHODS: A community-based cross-sectional survey was conducted between July and November 2017 enrolling participants of all ages in households from 15 villages in four border regions of Tanzania: Geita, Kigoma, Mtwara and Ruvuma. All participants had an RDT performed in the field and provided a blood sample for later laboratory multiplex antigen detection of HRP2. In assessing the continuous HRP2 levels in participant blood versus RDT result, dose–response logistic regression provided quantitative estimates for HRP2 limit of detection (LOD). RESULTS: From the 15 study villages, 6941 persons were enrolled that had a RDT at time of enrollment and provided a DBS for later laboratory antigen detection. RDT positive prevalence for the HRP2 band by village ranged from 20.0 to 43.6%, but the magnitude of this prevalence did not have an effect on the estimated LOD of RDTs utilized in different villages. Overall, HRP2 single-target tests had a lower LOD at the 95% probability of positive RDT (4.3 ng/mL; 95% CI 3.4–5.4) when compared to pLDH/HRP2 dual target tests (5.4 ng/mL; 4.5–6.3), though this difference was not significant. With the exception of one village, all other 14 villages (93.3%) showed RDT LOD estimates at 90% probability of positive RDT between 0.5 and 12.0 ng/mL. CONCLUSIONS: Both HRP2-only and pLDH/HRP2 combo RDTs utilized in a 2017 Tanzania cross-sectional survey of border regions generally performed well, and reliably detected HRP2 antigen in the low ng/mL range. Though single target tests had lower levels of HRP2 detection, both tests were within similar ranges among the 15 villages. Comparison of quantitative HRP2 detection limits among study sites can help interpret RDT testing results when generating population prevalence estimates for malaria infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04383-4.
format Online
Article
Text
id pubmed-9714097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97140972022-12-02 Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017 Rogier, Eric Bakari, Catherine Mandara, Celine I. Chiduo, Mercy G. Plucinski, Mateusz Nace, Douglas Battle, Nastassia Chacky, Franky Rumisha, Susan F. Molteni, Fabrizio Mandike, Renata Mkude, Sigsbert Njau, Ritha Mohamed, Ally Udhayakumar, Venkatachalam Ishengoma, Deus S. Malar J Research BACKGROUND: Malaria rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen are widely used for detection of active infection with this parasite and are the only practical malaria diagnostic test in some endemic settings. External validation of RDT results from field surveys can confirm appropriate RDT performance. METHODS: A community-based cross-sectional survey was conducted between July and November 2017 enrolling participants of all ages in households from 15 villages in four border regions of Tanzania: Geita, Kigoma, Mtwara and Ruvuma. All participants had an RDT performed in the field and provided a blood sample for later laboratory multiplex antigen detection of HRP2. In assessing the continuous HRP2 levels in participant blood versus RDT result, dose–response logistic regression provided quantitative estimates for HRP2 limit of detection (LOD). RESULTS: From the 15 study villages, 6941 persons were enrolled that had a RDT at time of enrollment and provided a DBS for later laboratory antigen detection. RDT positive prevalence for the HRP2 band by village ranged from 20.0 to 43.6%, but the magnitude of this prevalence did not have an effect on the estimated LOD of RDTs utilized in different villages. Overall, HRP2 single-target tests had a lower LOD at the 95% probability of positive RDT (4.3 ng/mL; 95% CI 3.4–5.4) when compared to pLDH/HRP2 dual target tests (5.4 ng/mL; 4.5–6.3), though this difference was not significant. With the exception of one village, all other 14 villages (93.3%) showed RDT LOD estimates at 90% probability of positive RDT between 0.5 and 12.0 ng/mL. CONCLUSIONS: Both HRP2-only and pLDH/HRP2 combo RDTs utilized in a 2017 Tanzania cross-sectional survey of border regions generally performed well, and reliably detected HRP2 antigen in the low ng/mL range. Though single target tests had lower levels of HRP2 detection, both tests were within similar ranges among the 15 villages. Comparison of quantitative HRP2 detection limits among study sites can help interpret RDT testing results when generating population prevalence estimates for malaria infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04383-4. BioMed Central 2022-12-01 /pmc/articles/PMC9714097/ /pubmed/36457087 http://dx.doi.org/10.1186/s12936-022-04383-4 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rogier, Eric
Bakari, Catherine
Mandara, Celine I.
Chiduo, Mercy G.
Plucinski, Mateusz
Nace, Douglas
Battle, Nastassia
Chacky, Franky
Rumisha, Susan F.
Molteni, Fabrizio
Mandike, Renata
Mkude, Sigsbert
Njau, Ritha
Mohamed, Ally
Udhayakumar, Venkatachalam
Ishengoma, Deus S.
Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title_full Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title_fullStr Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title_full_unstemmed Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title_short Performance of antigen detection for HRP2-based malaria rapid diagnostic tests in community surveys: Tanzania, July–November 2017
title_sort performance of antigen detection for hrp2-based malaria rapid diagnostic tests in community surveys: tanzania, july–november 2017
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714097/
https://www.ncbi.nlm.nih.gov/pubmed/36457087
http://dx.doi.org/10.1186/s12936-022-04383-4
work_keys_str_mv AT rogiereric performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT bakaricatherine performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT mandaracelinei performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT chiduomercyg performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT plucinskimateusz performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT nacedouglas performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT battlenastassia performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT chackyfranky performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT rumishasusanf performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT moltenifabrizio performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT mandikerenata performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT mkudesigsbert performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT njauritha performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT mohamedally performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT udhayakumarvenkatachalam performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017
AT ishengomadeuss performanceofantigendetectionforhrp2basedmalariarapiddiagnostictestsincommunitysurveystanzaniajulynovember2017